neprilysin

Summary

Summary: Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.

Top Publications

  1. ncbi In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin
    Hui Huang
    Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA
    Neurotoxicology 32:300-6. 2011
  2. ncbi Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity
    Petra A B Klemmt
    Nuffield Department of Obstetrics and Gynaecology, The Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom
    Fertil Steril 85:564-72. 2006
  3. ncbi Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease
    Yinxing Liu
    Department of Molecular and Cellular Biochemistry, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
    Mol Ther 17:1381-6. 2009
  4. ncbi Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity
    James Scott Miners
    Dementia Research Group, Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Frenchay, Bristol, United Kingdom
    J Neuropathol Exp Neurol 68:902-14. 2009
  5. ncbi Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation
    Takashi Saito
    Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2 1 Hirosawa, Wako Shi, Saitama 351 0198, Japan
    Nat Med 11:434-9. 2005
  6. ncbi HIV-1 Tat inhibits neprilysin and elevates amyloid beta
    Hans C Rempel
    Department of Laboratory Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    AIDS 19:127-35. 2005
  7. ncbi Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels
    E Hellström-Lindahl
    Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Molecular Neuropharmacology, Geriatric lab, Novum, Floor 4, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:210-21. 2008
  8. ncbi Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide
    E Hama
    Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
    Med Hypotheses 65:498-500. 2005
  9. ncbi CD10 expression in stromal cells of ameloblastoma variants
    Giovanna Iezzi
    Research Fellow, Dental School, University of Chieti Pescara, Chieti Pescara, Italy
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:206-9. 2008
  10. ncbi NEP-like endopeptidases and Alzheimer's disease [corrected]
    R A Marr
    Department of Neuroscience, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA
    Curr Alzheimer Res 7:223-9. 2010

Research Grants

  1. NEURAL REGULATION OF PANCREATIC FUNCTION
    KIMBERLY SAUNDERS contact KIRKWOOD; Fiscal Year: 2010
  2. NEURAL REGULATION OF PANCREATIC FUNCTION
    KIMBERLY SAUNDERS contact KIRKWOOD; Fiscal Year: 2010
  3. NEUROPEPTIDE DEGRADATION IN THE SMALL INTESTINE
    Nigel Bunnett; Fiscal Year: 1993
  4. NEUROGENIC MECHANISMS OF INTESTINAL INFLAMMATION
    Eileen Grady; Fiscal Year: 2006
  5. Prevention of Diabetic Neuropathy with ACE Inhibitors
    MARK ANTHONY YOREK; Fiscal Year: 2010
  6. Prevention of Diabetic Neuropathy with ACE Inhibitors
    Mark Yorek; Fiscal Year: 2009
  7. INTRARENAL REGULATION OF SODIUM EXCRETION
    John Burnett; Fiscal Year: 2004
  8. NEURAL REGULATION OF PANCREATIC FUNCTION
    Kimberly Kirkwood; Fiscal Year: 2002
  9. NEUROGENIC MECHANISMS OF INTESTINAL INFLAMMATION
    Eileen Grady; Fiscal Year: 1999
  10. INTRARENAL REGULATION OF SODIUM EXCRETION
    John Burnett; Fiscal Year: 2000

Detail Information

Publications232 found, 100 shown here

  1. ncbi In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin
    Hui Huang
    Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA
    Neurotoxicology 32:300-6. 2011
    ..b>Neprilysin (NEP), a rate-limiting catabolic peptidase is involved in Aβ metabolism in vivo...
  2. ncbi Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity
    Petra A B Klemmt
    Nuffield Department of Obstetrics and Gynaecology, The Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom
    Fertil Steril 85:564-72. 2006
    ..Loss of differentiation capacity of the endometriotic cell lines and endometrial cells from women with endometriosis may influence the capacity for proliferation and survival of these cells in the ectopic environment...
  3. ncbi Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease
    Yinxing Liu
    Department of Molecular and Cellular Biochemistry, University of Kentucky, College of Medicine, Lexington, Kentucky, USA
    Mol Ther 17:1381-6. 2009
    b>Neprilysin (NEP) is a zinc metallopeptidase that efficiently degrades the amyloid beta (Abeta) peptides believed to be involved in the etiology of Alzheimer disease (AD)...
  4. ncbi Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity
    James Scott Miners
    Dementia Research Group, Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Frenchay, Bristol, United Kingdom
    J Neuropathol Exp Neurol 68:902-14. 2009
    Experimental reduction of neprilysin (NEP) or insulin-degrading enzyme (IDE) in vivo exacerbates beta-amyloid accumulation in the brain...
  5. ncbi Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation
    Takashi Saito
    Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2 1 Hirosawa, Wako Shi, Saitama 351 0198, Japan
    Nat Med 11:434-9. 2005
    ..pathogenic agent of Alzheimer disease, in the brain through modulating proteolytic degradation catalyzed by neprilysin. Among various effector candidates, only somatostatin upregulated neprilysin activity in primary cortical ..
  6. ncbi HIV-1 Tat inhibits neprilysin and elevates amyloid beta
    Hans C Rempel
    Department of Laboratory Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    AIDS 19:127-35. 2005
    ..lengthened the life expectancy of individuals infected with HIV-1, we investigated the affect of HIV-1 Tat, a viral transactivating transcription factor, on Abeta degradation in the brain by neprilysin (NEP), a neuronal endopeptidase.
  7. ncbi Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels
    E Hellström-Lindahl
    Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Division of Molecular Neuropharmacology, Geriatric lab, Novum, Floor 4, S 141 86 Stockholm, Sweden
    Neurobiol Aging 29:210-21. 2008
    ..b>Neprilysin has been shown to be an important enzyme to degrade A beta in brain...
  8. ncbi Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide
    E Hama
    Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
    Med Hypotheses 65:498-500. 2005
    We recently demonstrated that amyloid beta peptide (Abeta) is catabolized primarily by a neutral endopeptidase, neprilysin, in the brain and that a neuropeptide, somatostatin (SST), regulates brain Abeta level via modulation of neprilysin ..
  9. ncbi CD10 expression in stromal cells of ameloblastoma variants
    Giovanna Iezzi
    Research Fellow, Dental School, University of Chieti Pescara, Chieti Pescara, Italy
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:206-9. 2008
    ....
  10. ncbi NEP-like endopeptidases and Alzheimer's disease [corrected]
    R A Marr
    Department of Neuroscience, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA
    Curr Alzheimer Res 7:223-9. 2010
    ..Of particular interest are endopeptidases that are sensitive to the neprilysin inhibitors thiorphan and phosphoramidon (i.e...
  11. ncbi Lack of hepatocellular CD10 along bile canaliculi is physiologic in early childhood and persistent in Alagille syndrome
    Jane A Byrne
    Division of Gene and Cell Based Therapy, King s College London School of Medicine, London, UK
    Lab Invest 87:1138-48. 2007
    ..Liver CD10 in childhood appears to undergo reduced synthesis or rapid degradation, which persists in AGS. Absence of CD10 expression thus may limit NEA as a marker of cholestasis in young patients and in AGS...
  12. ncbi Neprilysin gene transfer reduces human amyloid pathology in transgenic mice
    Robert A Marr
    Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA
    J Neurosci 23:1992-6. 2003
    ..b>Neprilysin has recently been implicated as a major extracellular Abeta degrading enzyme in the brain...
  13. ncbi Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin
    Yvonne S Eisele
    Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tubingen, D 72076 Tubingen, Germany
    Mol Biol Cell 18:3591-600. 2007
    ..with the increase in AICD, Gleevec leads to elevated mRNA and protein levels of the Abeta-degrading enzyme neprilysin, a potential target gene of AICD-regulated transcription...
  14. ncbi Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes
    Lilia Fisk
    Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Mount Preston Street, Leeds, LS2 9JT, UK
    Neurochem Res 32:1741-8. 2007
    ..brain has an endogenous mechanism of Abeta removal via proteolytic degradation and the zinc metalloproteinase neprilysin (NEP) is a critical regulator of Abeta concentration. Down-regulation of NEP could predispose to AD...
  15. ncbi Neprilysin protects neurons against Abeta peptide toxicity
    Salim S El-Amouri
    Department of Molecular and Cellular Biochemistry, Medical University of South Carolina, Charleston, SC 29425, USA
    Brain Res 1152:191-200. 2007
    ..b>Neprilysin (NEP) appears to be the most potent Abeta peptide-degrading enzyme in the brain...
  16. ncbi Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
    Luis Miguel Ruilope
    Division of Hypertension, Hospital 12 de Octubre, Madrid, Spain
    Lancet 375:1255-66. 2010
    LCZ696 is a first-in-class inhibitor of the angiotensin II receptor and neprilysin. We aimed to establish whether the dual actions of LCZ696 lead to further lowering of blood pressure, compared with the angiotensin-receptor blocker ..
  17. ncbi CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation
    A Piattelli
    Dental School, University of Chieti Pescara, Chieti, Italy
    Oral Dis 12:301-4. 2006
    ..CD10 is expressed on the majority of follicle-center lymphomas and Burkitt lymphomas. CD10 has also been shown to be present in a variety of other neoplasms...
  18. ncbi Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas
    Yin Xu
    Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9073, USA
    Mod Pathol 15:413-9. 2002
    ..Our results indicate 75% sensitivity and 100% specificity of CD10 expression by IHC compared with multiparameter FC with cluster analysis and a 6% technical failure rate...
  19. ncbi Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease
    John B Rose
    Department of Neurosciences, University of California, San Diego, La Jolla, California 92093 0624, USA
    J Neurosci 29:1115-25. 2009
    The endopeptidase neprilysin (NEP) is a major amyloid-beta (Abeta) degrading enzyme and has been implicated in the pathogenesis of Alzheimer's disease...
  20. ncbi Neprilysin 4, a novel endopeptidase from Drosophila melanogaster, displays distinct substrate specificities and exceptional solubility states
    Heiko Meyer
    Department of Zoology Developmental Biology, University of Osnabruck, Germany
    J Exp Biol 212:3673-83. 2009
    ..Here we report on the identification and first characterization of neprilysin 4 (NEP4) from Drosophila melanogaster...
  21. ncbi Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme
    J Scott Miners
    Dementia Research Group, Institute of Clinical Neurosciences, Clinical Science at North Bristol, University of Bristol, Bristol, UK
    Brain Pathol 20:794-802. 2010
    ..We measured BACE-1 activity and the levels and activities of neprilysin (NEP), insulin-degrading enzyme (IDE) and angiotensin-converting enzyme (ACE) in normal control brains (16 years-..
  22. ncbi Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin
    Kaiwei Liang
    State Key Lab of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China
    J Biol Chem 285:935-42. 2010
    ..we provide evidence that estrogen promotes Abeta degradation mainly through a principal Abeta degrading enzyme, neprilysin, in neuroblastoma SH-SY5Y cells...
  23. ncbi Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease
    Nikolai D Belyaev
    Faculty of Biological Sciences, Institute of Molecular and Cellular Biology, University of Leeds, Leeds, UK
    EMBO Rep 10:94-100. 2009
    ..domain of the amyloid precursor protein (AICD) regulates expression of the Abeta-degrading metalloprotease, neprilysin (NEP)...
  24. ncbi Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities
    James Scott Miners
    Dementia Research Group, Institute of Clinical Neurosciences, University of Bristol, Bristol, UK
    J Alzheimers Dis 23:101-8. 2011
    ..disease (AD)-related increases in the activities of β-secretase (BACE-1) and Aβ-degrading enzymes including neprilysin (NEP) and angiotensin-converting enzyme (ACE) in the frontal cortex...
  25. ncbi Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
    Brian Spencer
    Department of Neurosciences, University of California San Diego, La Jolla, California 92093, USA
    BMC Neurosci 9:109. 2008
    ..The endopeptidase, neprilysin, has been implicated as a major Abeta degrading enzyme in mice and humans...
  26. ncbi Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice
    William J Meilandt
    Gladstone Institute of Neurological Disease, University of California, San Francisco, California 94158, USA
    J Neurosci 29:1977-86. 2009
    ..Overexpression of the Abeta-degrading enzyme neprilysin in brains of human amyloid precursor protein (hAPP) transgenic mice decreases overall Abeta levels and amyloid ..
  27. ncbi Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease
    Matthew L Hemming
    Center for Neurologic Diseases, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Neurobiol Dis 26:273-81. 2007
    ..Furthermore, we find no change in plaque deposition or in peripheral Abeta levels. Data from these Alzheimer models suggest that captopril and similar ACE inhibitors do not cause Abeta accumulation in vivo...
  28. ncbi Metabolic regulation of brain Abeta by neprilysin
    N Iwata
    Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako shi 351 0198 Japan
    Science 292:1550-2. 2001
    ..We examined the role of neprilysin, a candidate Abeta-degrading peptidase, in the metabolism using neprilysin gene-disrupted mice...
  29. ncbi Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
    Gillian I Rice
    Proteolysis Research Group, School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK
    Biochem J 383:45-51. 2004
    ..cleavage by full-length human ACE, the separate N- and C-domains of ACE, the homologue of ACE, ACE2, and NEP (neprilysin)...
  30. ncbi Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
    Malcolm A Leissring
    Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Harvard Medical School, Boston, MA 02115, USA
    Neuron 40:1087-93. 2003
    ..Here we show that transgenic overexpression of insulin-degrading enzyme (IDE) or neprilysin (NEP) in neurons significantly reduces brain Abeta levels, retards or completely prevents amyloid plaque ..
  31. ncbi Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases
    K Shirotani
    Laboratory for Proteolytic Neuroscience, Brain Science Institute, RIKEN, 2 1 Hirosawa, Wako Shi, Saitama 351 0198, Japan
    J Biol Chem 276:21895-901. 2001
    ..1-42-degrading enzyme whose activity is inhibited by thiorphan and phosphoramidon in vivo, we searched for neprilysin (NEP) homologues and cloned neprilysin-like peptidase (NEPLP) alpha, NEPLP beta, and NEPLP gamma cDNAs...
  32. ncbi Clearance of Alzheimer's Abeta peptide: the many roads to perdition
    R E Tanzi
    Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown 02129, USA
    Neuron 43:605-8. 2004
    ..This minireview will summarize pathways involved in the removal of cerebral Abeta, including enzymatic degradation and receptor-mediated efflux out of the brain...
  33. ncbi Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea
    Shereen Ayoub
    , , , 14195 Berlin, Germany
    J Pharm Pharmacol 58:495-501. 2006
    ..It is suggested that the enhancement of cellular neutral endopeptidase activity by green tea extract and its natural products might be correlated with an elevated level of intracellular cyclic adenosine monophosphate...
  34. ncbi Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit
    Raphael Poirier
    Division of Psychiatry Research, University of Zurich, August Forel Strasse 1, Zurich 8008, Switzerland
    Neurobiol Dis 24:475-83. 2006
    ..Lowering brain Abeta levels, therefore, is a therapeutic strategy for the treatment of AD. Neuronal neprilysin upregulation led to increased degradation of Abeta, reduced the formation of Abeta-plaques and the associated ..
  35. ncbi CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis
    K Ohshima
    First Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jonan-ku, Fukuoka 814-01, Japan
    Histopathology 39:156-62. 2001
    ..Overall, our results suggest that CD10 expression may be useful, in combination with clinical parameters, for determining the prognosis of DLBCL...
  36. ncbi M13 endopeptidases: New conserved motifs correlated with structure, and simultaneous phylogenetic occurrence of PHEX and the bony fish
    Laurent Bianchetti
    Institut de Génétique et de Biologie Moléculaire et Cellulaire CNRS, INSERM, ULP, Illkirch, France
    Proteins 47:481-8. 2002
    ..Using the recently solved neprilysin structure, we have observed that all new motifs, except one, localize in the spatial vicinity of the previously ..
  37. ncbi Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation
    H H Kramer
    Department of Neurology, Johannes Gutenberg University, Langenbeckstr 1, 55101 Mainz, Germany
    Exp Neurol 195:179-84. 2005
    ..Our findings suggest that NEP but not ACE is most important for CGRP degradation in human skin. This may be of particular importance for the understanding of pain disorders like migraine or complex regional pain syndrome...
  38. ncbi Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP
    Damiano Rizzoni
    Department of Medical and Surgical Sciences, University of Brescia, DMCS Clinica Medica 4, University of Padua, Italy
    J Hypertens 22:759-66. 2004
    ....
  39. ncbi Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies
    Randal A Skidgel
    Department of Pharmacology, University of Illinois College of Medicine, Pharmacology (MC 868, 835 S. Wolcott Avenue, Chicago, IL 60612-7344, USA
    Peptides 25:521-5. 2004
    ..extended to the hydrolysis of the neuropeptide, neurotensin and to compare hydrolysis of the same peptides by neprilysin (neutral endopeptidase 24.11, CD10, NEP)...
  40. ncbi Substance P and neutral endopeptidase in development of acute respiratory distress syndrome following fire smoke inhalation
    Simon S Wong
    Department of Pediatrics Critical Care Medicine, The University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA
    Am J Physiol Lung Cell Mol Physiol 287:L859-66. 2004
    ....
  41. ncbi B lymphopoiesis is active throughout human life, but there are developmental age-related changes
    Maria Isabel D Rossi
    Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City 73104, USA
    Blood 101:576-84. 2003
    ..Dramatic changes in human B lymphopoiesis occur early in life, and more information is required to construct a probable sequence of differentiation events prior to the acquisition of CD10...
  42. ncbi Neutral endopeptidase protein expression and prognosis in localized prostate cancer
    Iman Osman
    Department of Urology, New York University Cancer Institute, Kaplan Comprehensive Cancer Center, New York, New York, USA
    Clin Cancer Res 10:4096-100. 2004
    ..We investigated whether decreased NEP expression in localized prostate cancers is associated with prostate-specific antigen (PSA) relapse after radical prostatectomy...
  43. ncbi Identification and localization of a neprilysin-like activity that degrades tachykinin-related peptides in the brain of the cockroach, Leucophaea maderae, and locust, Locusta migratoria
    R Elwyn Isaac
    Molecular and Cellular Biosciences, Faculty of Biological Sciences, Miall Building, University of Leeds, Leeds, LS2 9JT, United Kingdom
    J Comp Neurol 457:57-66. 2003
    b>Neprilysin (NEP) is an endopeptidase, which has an important role in the inactivation of mammalian tachykinins...
  44. ncbi CD10 expression in diffuse large B-cell lymphomas does not influence survival
    Bettina Fabiani
    , , AP-HP, Paris, France
    Virchows Arch 445:545-51. 2004
    ..44 and P=0.34 respectively). Therefore, it appears that CD10 expression does not influence survival or event-free survival in DLBCL...
  45. ncbi Involvement of neutral endopeptidase in neoplastic progression
    Makoto Sumitomo
    Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan
    Biochim Biophys Acta 1751:52-9. 2005
    ..We review the mechanisms of NEP's tumor suppressive action and how NEP loss contributes to tumor progression...
  46. ncbi Roles of neutral endopeptidase in airways
    D B Borson
    Department of Physiology, University of California, San Francisco 94143 0911
    Am J Physiol 260:L212-25. 1991
    ....
  47. ncbi Mechanisms of toxic smoke inhalation and burn injury: role of neutral endopeptidase and vascular leakage in mice
    Sam Jacob
    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77550, USA
    Toxicol Mech Methods 19:191-6. 2009
    ..026) as compared to mice with SB injury alone. In conclusion the current study indicates that specific NEP inhibitor CGS 24592 exacerbates the SB-induced lung injury and inflammation in mice...
  48. ncbi Novel strategies for Alzheimer's disease treatment
    Brian Spencer
    University of California, Department of Neurosciences, San Diego, La Jolla, CA 92093 0624, USA
    Expert Opin Biol Ther 7:1853-67. 2007
    ..g., neprilysin)...
  49. ncbi Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle
    Aldobrando Broccolini
    Department of Neuroscience, Catholic University, School of Medicine, Rome, Italy
    J Neurochem 105:971-81. 2008
    ..h-IBM muscle shows the abnormal accumulation of proteins including amyloid-beta (Abeta). Neprilysin (NEP), a metallopeptidase that cleaves Abeta, is characterized by the presence of several N-glycosylation sites, ..
  50. ncbi Neprilysin and amyloid beta peptide degradation
    Louis B Hersh
    Department of Molecular and Cellular Biochemistry and the Center for Structural Biology, University of Kentucky, Lexington, KY 40536, USA
    Curr Alzheimer Res 5:225-31. 2008
    b>Neprilysin is a zinc metalloendopeptidase with relatively broad substrate specificity. The enzyme is localized to the plasma membrane of cells where it can function to degrade extracellular peptides...
  51. ncbi Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease
    Salim S El-Amouri
    Department of Molecular and Cellular Biochemistry, Medical University of South Carolina, Charleston, SC 29425, USA
    Am J Pathol 172:1342-54. 2008
    ..b>Neprilysin (NEP) is the dominant Abeta peptide-degrading enzyme in the brain; NEP becomes inactivated and down-regulated ..
  52. ncbi Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and prem
    Kanae Iijima-Ando
    Laboratory of Neurogenetics and Pathobiology, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J Biol Chem 283:19066-76. 2008
    The amyloid-beta42 (Abeta42) peptide has been suggested to play a causative role in Alzheimer disease (AD). Neprilysin (NEP) is one of the rate-limiting Abeta-degrading enzymes, and its enhancement ameliorates extracellular amyloid ..
  53. ncbi Neutral endopeptidase modulation of septic shock
    B Lu
    Ina Sue Perlmutter Laboratory, Children s Hospital, Boston, Massachusetts, USA
    J Exp Med 181:2271-5. 1995
    ..This unexpected finding indicates an important protective role for NEP in septic shock...
  54. ncbi Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
    E Malito
    Ben May Department for Cancer Research, The University of Chicago, 929 East 57th Street, Chicago, IL 60637, United States
    Cell Mol Life Sci 65:2574-85. 2008
    ..Insulin degrading enzyme and neprilysin are involved in the clearance of Abeta, and presequence peptidase is suggested to play a role in the degradation ..
  55. ncbi The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells
    Kun Lin Chen
    Department of Neurology and The Topnotch Stroke Research Center, Taipei Medical University, 250 Wu Hsing Street, Taipei 110, Taiwan
    Biochem Biophys Res Commun 378:57-61. 2009
    ..It therefore remains largely unknown as to whether Abeta does in fact cause DNA methylation/demethylation. Neprilysin (NEP) is one of the enzymes responsible for Abeta degradation, with its expression decreasing in both Alzheimer ..
  56. ncbi Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease
    Hanjun Guan
    Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0509, USA
    J Neurosci Res 87:1462-73. 2009
    ..a novel strategy for lowering amyloid burden in the brain by peripherally expressing the Abeta-degrading enzyme neprilysin on leukocytes in the 3xTg-AD mouse model of Alzheimer's disease...
  57. ncbi Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy
    Wesley Farris
    Center for Neurologic Diseases, Department of Neurology, Harvard Institutes of Medicine, Room 730, Boston, MA 02115, USA
    Am J Pathol 171:241-51. 2007
    ..There is evidence that the Abeta-degrading protease neprilysin (NEP) is down-regulated in normal aging and LOAD...
  58. ncbi Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways
    Eva Sanz
    Departamento de Medicina, Universidad de Alcala, Alcalá de Henares 28805, Spain
    Proc Natl Acad Sci U S A 107:5925-30. 2010
    ..Here, we show a similar divergence in human B-cell development pathways between the Pax5(+)TdT(-) pre/pro-B differentiation pathway that gives rise to infant B-lineage leukemias and the early-B pathway...
  59. ncbi Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon
    C Oefner
    Pharma Preclinical Research, F Hoffmann La Roche Ltd, Basel, CH 4070, Switzerland
    J Mol Biol 296:341-9. 2000
    ..The inhibitor is bound to one side of this cavity and its binding mode provides a detailed understanding of the ligand-binding and specificity determinants...
  60. ncbi Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease
    Eric P Davidson
    Department of Veterans Affairs Iowa City Health Care System, Iowa City, IA 52246, USA
    Diabetes 56:355-62. 2007
    ..These studies suggest that vasopeptidase inhibitors may be an effective approach for the treatment of diabetic vascular and neural dysfunction...
  61. ncbi Signal pathway involved in increased expression of neutral endopeptidase 24.11 by gonadotropin releasing hormone in choriocarcinoma cells
    F Kikkawa
    Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai cho 65, Showa Ku, Nagoya 466 8550, Japan
    Placenta 25:176-83. 2004
    ..In conclusion, GnRH induces NEP expression by PKC delta and p38MAPK, and increased NEP expression may be involved in antiproliferative effect in BeWo cells...
  62. ncbi Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats
    V Arbin
    Laboratoire de Pharmacologie, U266 INSERM, UMR 8600 CNRS, U F R des Sciences Pharmaceutiques et Biologiques, Paris, France
    Br J Pharmacol 130:1297-304. 2000
    ..These effects are linked to an increased activation of the kinin-NO pathway. BK could lead to NO production by BK B2 receptor activation and another pathway in which kininase I may be involved...
  63. ncbi Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats
    Lu Ying
    INSERM U489, , 4, rue de la Chine, 75970 Paris Cedex 20, France
    Hypertension 42:937-44. 2003
    ..These results demonstrate that, in nitric oxide-deficient rats fed a normal-sodium diet, ACE and vasopeptidase inhibitors exhibit a marked renoprotective effect, whereas these treatments are less efficient in rats fed a high-sodium diet...
  64. ncbi In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position
    N Inguimbert
    , U266 INSERM-FRE 2463 CNRS, UFR des Sciences Pharmaceutiques et Biologiques, 4 avenue de l'Observatoire, 75270 Paris, Cedex 06, France
    J Pept Res 63:99-107. 2004
    ..We have previously reported the synthesis of a triple inhibitor able to simultaneously inhibit neprilysin (NEP, EC 3.4.24.11), angiotensin-converting enzyme (ACE, EC 3.4.15...
  65. ncbi Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma
    Michael Frost
    Division of Anatomic Pathology, University of Utah Health Sciences Center, Salt Lake City, USA
    Am J Clin Pathol 121:384-92. 2004
    ..Thus, pediatric BL and DLBCL have distinctive immunohistochemical profiles, and staining for c-myc, MIB-1, and bcl-2 might be useful in morphologically difficult cases...
  66. ncbi Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protei
    Maria Bai
    Department of Pathology, Medical Faculty, University of Ioannina, Ioannina, Greece
    Mod Pathol 17:847-56. 2004
    ....
  67. ncbi Antigen preservation in infarcted nodal B-cell lymphoma, with special reference to follicular center cell markers
    Masaru Kojima
    Department of Pathology and Clinical Laboratories, Gunma Cancer Center Hospital, Ohta, Japan
    Int J Surg Pathol 12:251-5. 2004
    ..However, BCL-2 (40%) and BCL-6 (0%) antigens were of little or no value in the infarcted lymphoid tissues...
  68. ncbi Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice
    Karin Jandeleit-Dahm
    The Baker Heart Research Institute, Vascular Division, Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia
    J Hypertens 23:2071-82. 2005
    ....
  69. ncbi Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas
    James R Cook
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Mod Pathol 16:879-85. 2003
    ..These findings indicate that a normal small subset of CD10+ peripheral T cells exists and, at least when present in small numbers, should not be considered an indication of a T-cell neoplasm...
  70. ncbi Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid
    Amanda J Newell
    Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, AZ 85351, USA
    Neurosci Lett 350:178-80. 2003
    ..Decreased degradation of Abeta is another possible disease mechanism. Neprilysin is a neutral endopeptidase that has been proposed to be the major enzyme responsible for Abeta degradation...
  71. ncbi Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
    J J Hoefnagel
    Department of Dermatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 149:1183-91. 2003
    ....
  72. ncbi Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases
    A Tzankov
    Institute of Pathology, University of Innsbruck, A-6020 Innsbruck, Austria
    J Clin Pathol 56:747-52. 2003
    ..Expression of CD44v6 correlates with disease stage, and might contribute to lymphoma dissemination. CD44v6 is expressed predominantly in ABC DLBCL, and in CD44 negative cases is associated with worse OS...
  73. ncbi Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes
    Maria Bai
    Department of Pathology, University of Ioannina, Ioannina, Greece
    Anticancer Res 24:3081-8. 2004
    ..In order to gain further insight into the apoptosis profile of DLBCL, 79 cases were investigated to determine whether distinct clusters of the combined expression levels of bcl2 family proteins can be identified in these lymphomas...
  74. ncbi CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme
    Angelo J Trapani
    Cardiovascular Diseases Research, Novartis Institutes for BioMedical Research, East Hanover, New Jersey 07936 1080, USA
    J Cardiovasc Pharmacol 44:S211-5. 2004
    ....
  75. ncbi Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium
    Daphne de Jong
    Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:805-12. 2007
    ....
  76. ncbi Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice
    Fadia Medja
    INSERM U676, , Paris, France
    Brain 129:3209-23. 2006
    ..In a broader context, these results also raise potential implications for the prevention of neurodegenerative diseases involving glutamate-mediated excitotoxic neuronal death...
  77. ncbi Neprilysin protects human neuronal progenitor cells against impaired development caused by amyloid-beta peptide
    Bozena Mazur-Kolecka
    Department of Developmental Neurobiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA
    Brain Res 1124:10-8. 2006
    ..Now we studied the effect of neprilysin, an Abeta-degrading enzyme, on development of neuronal colonies from neurospheres of HNPCs in the presence of ..
  78. ncbi Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders
    Henry Krum
    NHMRC Centre of Clinical Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University Alfred Hospital, Central and Eastern Clinical School, Melbourne, Victoria 3004, Australia
    J Hypertens 25:25-35. 2007
    ..Finally, ACE2 augmentation, antisense gene strategies, and vaccination against the renin-angiotensin system should still be considered experimental, but have significant appeal as additional approaches to the blockade of this system...
  79. ncbi Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases
    X Frank Zhao
    Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA
    Am J Clin Pathol 127:47-54. 2007
    ..These findings suggest that pediatric and adult PBL-DLBCLs are distinct entities...
  80. ncbi Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy
    H Veelken
    Department of Internal Medicine I Hematology Oncology, Freiburg University Medical Center, Freiburg, Germany
    Ann Oncol 18:931-9. 2007
    ..Biological parameters, including expression of Bcl-6, Bcl-2, CD10, major histocompatibility complex class II, and categorization as germinal center (GC) type have been described as IPI-independent prognostic factors...
  81. ncbi Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries
    Disney O Sivieri
    Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto USP, Ribeirao Preto, Sao Paulo, Brazil
    Hypertension 50:110-5. 2007
    ..These data demonstrated that ACE inhibitor-induced potentiation of BK vasodilator effects is not related to their actions on BK degradation...
  82. ncbi Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases
    Klaus Willenbrock
    Senckenbergisches Institut für Pathologie, Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main, Frankfurt am Main, Germany
    Br J Haematol 138:733-9. 2007
    ..This might be relevant in the development of secondary lymphomas...
  83. ncbi t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma
    Miyuki Hayama
    Department of Hematology, Kitasato University, Sagamihara shi, Kanagawa, Japan
    Int J Hematol 86:147-9. 2007
    ..Regarding CD5+CD10+ diffuse large B-cell lymphoma with a non-random chromosomal translocation of t(6;14)(q15;q32), studies on the mechanism of lymphomagenesis are needed...
  84. ncbi Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma
    Gustaaf W van Imhoff
    Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    J Clin Oncol 24:4135-42. 2006
    ....
  85. ncbi CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme
    Bruno Battistini
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste Foy, QC G1V 4G5, Canada
    Cardiovasc Drug Rev 23:317-30. 2005
    ..Similar in vivo ACE, NEP, and ECE inhibitory activities were also observed with the orally active prodrug, CGS 37808 (L-tryptophan, N-[[1-[[(2S)-2-(acetylthio)-4-methyl-1-oxopentyl]amino]cyclopentyl]-carbonyl]-, methyl ester...
  86. ncbi Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats
    Christa Thöne-Reinke
    German Institute of Nutrition, Bergholz Rehbrücke, Germany
    J Cardiovasc Pharmacol 44:S76-9. 2004
    ..It was found that SLV306 decreases renal matrix protein content as well as protein and albumin excretion in diabetic rats independent of blood pressure. These effects are comparable to those of angiotensinconverting enzyme inhibition...
  87. ncbi AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
    Christian Hoffmann
    Infectious Diseases Outpatient Clinic, II Department of Medicine, Universitatsklinikum Schleswig Holstein, Campus Kiel, Chemnitzstrasse 33, 24116 Kiel, Germany
    Blood 106:1762-9. 2005
    ..04). In summary, lack of CD20 or CD10 expression and a post-germinal center signature are associated with a worse prognosis in ARL...
  88. ncbi Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma
    John A Ozolek
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Laryngoscope 115:1097-100. 2005
    ..CD10 and CK20 were the most useful markers to distinguish metastatic renal cell carcinoma from oncocytomas in the salivary gland, whereas RCC, EMA, CK7, and vimentin are not as useful...
  89. ncbi Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma
    Eugenia Haralambieva
    Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands
    Am J Surg Pathol 29:1086-94. 2005
    ..Immunohistochemistry for Ki-67, CD10, and bcl2 with analysis of MYC and preferably also BCL2 and BCL6 may be advised as a marker panel for this diagnostic dilemma...
  90. ncbi Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study
    Scott D Solomon
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02445, USA
    Am Heart J 150:257-62. 2005
    ..Angiotensin-converting enzyme (ACE) inhibition attenuates ventricular remodeling and improves ventricular function in heart failure patients. Vasopeptidase inhibition has shown similar effects in experimental models...
  91. ncbi Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition
    Virginie Mellin
    INSERM U644, IFRMP No. 23, Rouen University Medical School, Rouen, France and Novarhis Institutes for BioMedical Research, East Hanover, New Jersey, USA
    J Cardiovasc Pharmacol 46:390-7. 2005
    ....
  92. ncbi Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation
    Marie Eve Moreau
    , , Room 3190, 2900 Blvd.Edouard-Montpetit, C.P. 6128, Succ Centre-Ville, , , Canada
    J Pharmacol Exp Ther 315:1065-74. 2005
    ..chain reaction analysis was developed and allowed the relative quantification of tissue's gene expression for neprilysin, membrane-bound aminopeptidase P (mAPP), and both B1 and B2 kinin receptor subtypes in tongue, parotid gland, ..
  93. ncbi Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis
    Anuradha Kanungo
    Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 19:25-33. 2006
    ..However, this combination of molecular abnormalities can also rarely occur in other neoplasms, such as the cases of low-grade B-cell lymphoma and plasmablastic myeloma in this study...
  94. ncbi Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats
    Philippe Daull
    Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste-Foy, QC, Canada
    Am J Hypertens 18:1606-13. 2005
    ..Only then it may constitute a first-in-class approach for the treatment of hypertension and other cardiovascular disorders...
  95. ncbi Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates
    Eduardo B Oliveira
    Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto USP, 14049 900 Ribeirao Preto, SP, Brazil
    Am J Physiol Heart Circ Physiol 293:H3550-7. 2007
    ..In conclusion, distinct BK-processing pathways operate in the perfusates of rat MAB and coronary bed, with a substantial participation of a des-Arg(9)-BK-forming enzyme identical to pancreatic CPB...
  96. ncbi Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I recept
    Chao-Hung Wang
    Department of Medicine, Division of Endocrinology and Metabolism, Toronto General Hospital and University Health Network, Toronto, Ontario, Canada
    Circulation 107:1923-9. 2003
    ..This effect is greater than that of ramipril and probably occurs at least in part via stimulation of the B2 receptor. OMA has the potential for greater type 2 diabetes prevention than ACEI...
  97. ncbi Vasopeptidase inhibitors: a new class of dual zinc metallopeptidase inhibitors for cardiorenal therapeutics
    Giuseppe Molinaro
    , , , , H3C 3J7, Canada
    Curr Opin Pharmacol 2:131-41. 2002
    ..However, like angiotensin-I-converting-enzyme inhibitors, vasopeptidase inhibitors are characterized by acute and chronic side-effects that need to be clarified...
  98. ncbi Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery
    Atsushi Miyamoto
    Department of Veterinary Pharmacology, Faculty of Agriculture, Kagoshima University, Kagoshima, 1 21 24 Korimoto, Kagoshima 890 0065, Japan
    Naunyn Schmiedebergs Arch Pharmacol 365:365-70. 2002
    ..These results suggest that BK-induced relaxation and contraction in the porcine basilar artery are enhanced by captopril and thiorphan which predominantly inhibit ACE activity localized on endothelial cells...
  99. ncbi N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities
    Nicolas Inguimbert
    , U266 INSERM, UMR 8600 CNRS, UFR des Sciences Pharmaceutiques et Biologiques, 4, avenue de l'Observatoire, 75270 Cedex 06, Paris, France
    Bioorg Med Chem Lett 12:2001-5. 2002
    We have previously reported the design of a lead compound 1a for the joint inhibition of neprilysin (NEP, EC 3.4.24.11), angiotensin converting enzyme (ACE, EC 3.4.15.1) and endothelin converting enzyme (ECE-1, EC 3.4.24...
  100. ncbi Vasopeptidase inhibition: a double-edged sword?
    Duncan John Campbell
    St Vincent s Institute of Medical Research and Department of Medicine, University of Melbourne, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia
    Hypertension 41:383-9. 2003
    ..Vasopeptidase inhibitors will therefore require careful evaluation before they are introduced to patient care...
  101. ncbi B-cell lymphomas with coexpression of CD5 and CD10
    Henry Y Dong
    IMPATH Inc, 521W 57th St, 6th Floor, New York, NY 10019, USA
    Am J Clin Pathol 119:218-30. 2003
    ..Investigation of bcl-1, bcl-6, and CD43 and morphologic evaluation may resolve the potential confusion in diagnosis and lead to the recognition of the correct lymphoma subtype...

Research Grants76

  1. NEURAL REGULATION OF PANCREATIC FUNCTION
    KIMBERLY SAUNDERS contact KIRKWOOD; Fiscal Year: 2010
    ....
  2. NEURAL REGULATION OF PANCREATIC FUNCTION
    KIMBERLY SAUNDERS contact KIRKWOOD; Fiscal Year: 2010
    ....
  3. NEUROPEPTIDE DEGRADATION IN THE SMALL INTESTINE
    Nigel Bunnett; Fiscal Year: 1993
    ..Knowledge of interaction between NEP, SPR and SP will provide basic information about the nature of peptidergic neurotransmission in the normal and inflamed intestine...
  4. NEUROGENIC MECHANISMS OF INTESTINAL INFLAMMATION
    Eileen Grady; Fiscal Year: 2006
    ..Together, the results of these experiments will provide new insights into peptide signaling, generate novel information about mechanisms of intestinal inflammation, and suggest new strategies for therapy. ..
  5. Prevention of Diabetic Neuropathy with ACE Inhibitors
    MARK ANTHONY YOREK; Fiscal Year: 2010
    ..If successful, these studies could provide a rationale for designing clinical studies to further test the efficacy of angiotensin converting enzyme and/or vasopeptidase inhibitor treatment in human diabetic neuropathy. ..
  6. Prevention of Diabetic Neuropathy with ACE Inhibitors
    Mark Yorek; Fiscal Year: 2009
    ..If successful, these studies could provide a rationale for designing clinical studies to further test the efficacy of angiotensin converting enzyme and/or vasopeptidase inhibitor treatment in human diabetic neuropathy. ..
  7. INTRARENAL REGULATION OF SODIUM EXCRETION
    John Burnett; Fiscal Year: 2004
    ..Aim 4: Establish that dietary sodium excess accelerates the development of cardiac remodeling and overt CHF in part via up-regulation of NEP. ..
  8. NEURAL REGULATION OF PANCREATIC FUNCTION
    Kimberly Kirkwood; Fiscal Year: 2002
    ..Using neurokinin receptor antagonists, peptidase inhibitors, and knockout mice, we will delineate the neurogenic mechanisms that regulate inflammation in acute pancreatitis. ..
  9. NEUROGENIC MECHANISMS OF INTESTINAL INFLAMMATION
    Eileen Grady; Fiscal Year: 1999
    ....
  10. INTRARENAL REGULATION OF SODIUM EXCRETION
    John Burnett; Fiscal Year: 2000
    ....
  11. TRANSGENIC MICE, INFLAMMATION & THE ALZHEIMER PHENOTYPE
    Marcia N Gordon; Fiscal Year: 2010
    ..b>Neprilysin is a major amyloid degrading protease, and a prime candidate for use in anti-amyloid gene therapy...
  12. Untangling Amyloid Plaques With Proteases
    Jin Moo Lee; Fiscal Year: 2010
    ..of some of these proteases in vivo have resulted in increased steady-state levels of brain A? in mice, including neprilysin (NEP), insulin-degrading enzyme (IDE), endothelin-converting enzyme (ECE)...
  13. Untangling Amyloid Plaques With Proteases
    Jin Moo Lee; Fiscal Year: 2009
    ..of some of these proteases in vivo have resulted in increased steady-state levels of brain A? in mice, including neprilysin (NEP), insulin-degrading enzyme (IDE), endothelin-converting enzyme (ECE)...
  14. Prevention of Diabetic Neuropathy with ACE Inhibitors
    Mark Yorek; Fiscal Year: 2007
    ..If successful, these studies could provide a rationale for designing clinical studies to further test the efficacy of ACE inhibitor treatment in human DN. ..
  15. A screen for small molecule inhibitors of soluble Abeta oligomer assembly
    Harry LeVine; Fiscal Year: 2007
    ..with compound, will be screened with trypsin, and if positive, digested with insulin-degrading enzyme and neprilysin, proteases believed to degrade Abeta peptides in vivo...
  16. DIABETIC NEUROPATHY: IMPLICATIONS FOR WOUND REPAIR
    Nicole Gibran; Fiscal Year: 2002
    ..Using an excisional would model in hyperglycemia db/db mice, we will replace substance P, replace NGF or inhibit neutral endopeptidase activity to evaluate the roles of neuropeptides and NGF in wound repair. ..
  17. The Role of Cathepsin B and Cystatin C in Alzheimer's Disease
    Li Gan; Fiscal Year: 2010
    ..However, unlike some other Abeta degradation enzymes, such as neprilysin (NEP, an endopeptidase with optimal activity at a neutral pH), CatB truncates Abeta at the C-terminus with ..
  18. GENES AND FIBRINOLYTIC CAPACITY OF HUMAN ENDOTHELIUM
    Nancy Brown; Fiscal Year: 2006
    ..It is expected that these pharmacogenetic studies will yield critical new information and strategies for enhancing the favorable effect of the kallikrein-kinin system on fibrinolysis and the risk of thrombotic cardiovascular events. ..
  19. LXR and PPARgamma mediated Abeta clearance mechanisms
    Gary Landreth; Fiscal Year: 2007
    ..that lipidated forms of ApoE facilitate the intracellular degradation of A¿ peptides by microglia through neprilysin- dependent proteolysis...
  20. LXR and PPARgamma mediated Abeta clearance mechanisms
    Gary Landreth; Fiscal Year: 2009
    ..We show that lipidated forms of ApoE facilitate the intracellular degradation of A peptides by microglia through neprilysin- dependent proteolysis...
  21. LXR and PPARgamma mediated Abeta clearance mechanisms
    Gary Landreth; Fiscal Year: 2009
    ..We show that lipidated forms of ApoE facilitate the intracellular degradation of A peptides by microglia through neprilysin- dependent proteolysis...